<DOC>
	<DOCNO>NCT01818076</DOCNO>
	<brief_summary>This study evaluate long-term safety botulinum toxin type A treatment moderate severe crow 's foot line repeat application .</brief_summary>
	<brief_title>Open Label Study Assess Long-term Safety Repeat Administration Botulinum Toxin Type A Moderate Severe Crow 's Feet Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe crow 's foot line Female male , 18 year age good general health Women childbearing potential must agree use effective method birth control course study Any neurological condition may place subject increase risk exposure botulinum toxin type A Muscle weakness paralysis , particularly area receive study treatment Active skin disease irritation treatment area Deep dermal scarring , inability smooth crow 's foot line treat manually spread skin apart Treatment botulinum toxin type A crow 's foot line last 3 month Chemical peel 9 month prior treatment Use prescription retinoid product 3 month prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>